Reported Tuberculosis in the United States, 2022
Table 33. Tuberculosis Genotyping Surveillance Coverage:1 Reporting Areas, 2022
| State | Total cases | Culture-positive cases | Genotyped cases | Genotype surveillance coverage2 (%) |
|---|---|---|---|---|
| United States3 | 8,331 | 6,610 | 6,343 | (96.0) |
| Alabama | 65 | 59 | 54 | (91.5) |
| Alaska | 95 | 68 | 68 | (100.0) |
| Arizona | 154 | 132 | 132 | (100.0) |
| Arkansas | 68 | 49 | 43 | (87.8) |
| California | 1,848 | 1,532 | 1,473 | (96.1) |
| Colorado | 57 | 52 | 52 | (100.0) |
| Connecticut | 67 | 51 | 51 | (100.0) |
| Delaware | 13 | 10 | 10 | (100.0) |
| District of Columbia | 15 | 12 | 12 | (100.0) |
| Florida | 535 | 419 | 414 | (98.8) |
| Georgia | 262 | 192 | 190 | (99.0) |
| Hawaii | 101 | 76 | 76 | (100.0) |
| Idaho | 11 | 8 | 8 | (100.0) |
| Illinois | 298 | 223 | 209 | (93.7) |
| Indiana | 99 | 73 | 73 | (100.0) |
| Iowa | 60 | 44 | 43 | (97.7) |
| Kansas | 52 | 44 | 39 | (88.6) |
| Kentucky | 70 | 51 | 50 | (98.0) |
| Louisiana | 95 | 86 | 56 | (65.1) |
| Maine | 17 | 13 | 13 | (100.0) |
| Maryland | 157 | 113 | 112 | (99.1) |
| Massachusetts | 153 | 132 | 122 | (92.4) |
| Michigan | 120 | 65 | 65 | (100.0) |
| Minnesota | 132 | 103 | 103 | (100.0) |
| Mississippi | 54 | 45 | 40 | (88.9) |
| Missouri | 69 | 59 | 55 | (93.2) |
| Montana | 6 | 5 | 0 | (0.0) |
| Nebraska | 29 | 22 | 20 | (90.9) |
| Nevada | 62 | 54 | 54 | (100.0) |
| New Hampshire | 11 | 9 | 6 | (66.7) |
| New Jersey | 289 | 230 | 227 | (98.7) |
| New Mexico | 30 | 23 | 23 | (100.0) |
| New York State4 | 178 | 137 | 121 | (88.3) |
| New York City | 536 | 460 | 448 | (97.4) |
| North Carolina | 163 | 128 | 127 | (99.2) |
| North Dakota | 10 | 5 | 5 | (100.0) |
| Ohio | 146 | 102 | 101 | (99.0) |
| Oklahoma | 80 | 52 | 45 | (86.5) |
| Oregon | 73 | 58 | 57 | (98.3) |
| Pennsylvania | 173 | 145 | 143 | (98.6) |
| Rhode Island | 17 | 10 | 9 | (90.0) |
| South Carolina | 101 | 74 | 73 | (98.6) |
| South Dakota | 10 | 7 | 7 | (100.0) |
| Tennessee | 106 | 71 | 67 | (94.4) |
| Texas | 1,098 | 874 | 827 | (94.6) |
| Utah | 33 | 24 | 24 | (100.0) |
| Vermont | 3 | 2 | 2 | (100.0) |
| Virginia | 195 | 150 | 149 | (99.3) |
| Washington | 251 | 201 | 195 | (97.0) |
| West Virginia | 11 | 9 | 7 | (77.8) |
| Wisconsin | 52 | 46 | 42 | (91.3) |
| Wyoming | 1 | 1 | 1 | (100.0) |
| American Samoa | –– | –– | –– | –– |
| Federated States of Micronesia | 51 | 27 | 27 | (100.0) |
| Guam | 59 | 52 | 52 | (100.0) |
| Republic of the Marshall Islands | 106 | 25 | 24 | (96.0) |
| Northern Mariana Islands | 23 | 14 | 6 | (42.9) |
| Puerto Rico | 22 | 20 | 19 | (95.0) |
| Republic of Palau | 7 | 5 | 5 | (100.0) |
| U.S. Virgin Islands | –– | –– | –– | –– |
1Genotype surveillance coverage is defined as the percentage of all culture-positive cases for which there was a genotyped isolate.
2National TB Performance Indicator goal for national TB genotyping surveillance coverage is 100.0%.
3American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.
4Excludes New York City.
Note:
Data for all years are updated through July 8, 2023.
Double dashes (––) indicate that data are not available.
See Technical Notes